FDA NDC Directory · JSON-LD · Markdown

Rivastigmine Transdermal System

NDC 51991-899 · HUMAN PRESCRIPTION DRUG · PATCH, EXTENDED RELEASE

Generic nameRivastigmine
Labeler / ManufacturerBreckenridge Pharmaceutical, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA209063
Dosage form / routePATCH, EXTENDED RELEASE · TRANSDERMAL
Active ingredientsRIVASTIGMINE (13.3 mg/24h)
Marketing started20191219
Package count1

External sources

Source: openFDA. Public-domain (CC0).